# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-26-016723
Filing Date
2026-04-24
Accepted
2026-04-24 16:25:16
Documents
22
Period of Report
2026-06-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20065754x1_def14a.htm iXBRL | DEF 14A | 1446829
5 | GRAPHIC | logo_bridgebio2.jpg | GRAPHIC | 36301
6 | GRAPHIC | ny20065754x1_piechart01.jpg | GRAPHIC | 144639
7 | GRAPHIC | ny20065754x1_piechart03.jpg | GRAPHIC | 127250
8 | GRAPHIC | ny20065754x1_pvp01.jpg | GRAPHIC | 226074
9 | GRAPHIC | ny20065754x1_pvp02.jpg | GRAPHIC | 189405
10 | GRAPHIC | ny20065754x1_pvp03.jpg | GRAPHIC | 173198
11 | GRAPHIC | ny20065754x1_pc1.jpg | GRAPHIC | 707378
12 | GRAPHIC | ny20065754x1_pc2.jpg | GRAPHIC | 572489
| Complete submission text file | 0001140361-26-016723.txt |  | 8301648

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | INLINE XBRL TAXONOMY EXTENSION - SCHEMA | bbio-20260622.xsd | EX-101.SCH | 3571
3 | INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE | bbio-20260622_lab.xml | EX-101.LAB | 5880
4 | INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE | bbio-20260622_pre.xml | EX-101.PRE | 1828
25 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20065754x1_def14a_htm.xml | XML | 374874

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38959 | Film No.: 26894519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)